AMERIPRISE FINANCIAL INC - TRIUS THERAPEUTICS INC CONTINGENT VALUE RIGHT ownership

TRIUS THERAPEUTICS INC CONTINGENT VALUE RIGHT's ticker is and the CUSIP is 896CVR990. A total of 1 filers reported holding TRIUS THERAPEUTICS INC CONTINGENT VALUE RIGHT in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of TRIUS THERAPEUTICS INC CONTINGENT VALUE RIGHT
ValueSharesWeighting
Q4 2016$0188,5290.0%0.00%
Q3 2016$0
-100.0%
188,5290.0%0.00%
Q2 2016$9,000
-47.1%
188,5290.0%0.00%
Q1 2016$17,0000.0%188,5290.0%0.00%
Q4 2015$17,000
+6.2%
188,5290.0%0.00%
Q3 2015$16,000
-50.0%
188,5290.0%0.00%
Q2 2015$32,000
+3.2%
188,5290.0%0.00%
Q1 2015$31,000
+3.3%
188,529
+1.0%
0.00%
Q4 2014$30,0000.0%186,7250.0%0.00%
Q3 2014$30,000
+3.4%
186,7250.0%0.00%
Q2 2014$29,000
+3.6%
186,7250.0%0.00%
Q1 2014$28,0000.0%186,7250.0%0.00%
Q4 2013$28,000
+3.7%
186,7250.0%0.00%
Q3 2013$27,000186,7250.00%
Other shareholders
TRIUS THERAPEUTICS INC CONTINGENT VALUE RIGHT shareholders Q4 2016
NameSharesValueWeighting ↓
AMERIPRISE FINANCIAL INC 188,529$00.00%
View complete list of TRIUS THERAPEUTICS INC CONTINGENT VALUE RIGHT shareholders